CD8A and cancer: The authors found a 37-gene TRM signature associated with better response to cancer treatments, using both multi-cell RNA-Seq of CD8+/CD103+ T cells (TRM phenotype) compared to CD8+/CD103− T cells, as well as single-cell RNA-Seq [26].